Ketones and Muscle Protein Synthesis

McGill University

Status: Completed

Conditions: Regulation of Muscle Protein Synthesis; Ketosis

Treatments: Dietary Supplement: Ketone; Dietary Supplement: Protein; Dietary Supplement: Ketone + Protein

Study type: Interventional

Funder types: Other

Identifiers

NCT04565444

A11-M51-19A

Details and patient eligibility

About

Ketones are natural substances normally produced by the body during prolonged fasting and starvation, or in response to a "ketogenic" diet to be used as fuel by the brain and muscles. Ketones are therefore similar to dietary proteins, carbohydrates and fats since they represent a source of energy for the body. In addition to serving as a source of energy, ketones have also been shown to stimulate increased rates of muscle protein synthesis in humans.

The ingestion of dietary protein is well established to stimulate an increase in the rate of protein synthesis in skeletal muscle. The rate of muscle protein synthesis can be maximized following the intake of 20g of protein. As a result, smaller doses of protein (i.e. 10g) represent a sub-optimal dose of protein because there is still room for improvement concerning muscle protein synthesis.

Recently ketone-containing food products have become available that elevate ketone levels in the body without the need for ketogenic diets or prolonged fasting. Therefore, the purpose of this study is to measure skeletal muscle protein synthesis rates after ingesting the following:

1. Ketone monoester
2. Ketone monoester supplemented with sub-optimal dose of whey protein
3. Sub-optimal dose of whey protein

It is hypothesized that muscle protein synthesis rates will increase following the ingestion of a ketone-containing beverage. Further, muscle protein synthesis rates will be enhanced when the ketone-containing beverage and sub-optimal protein dose are taken together.

Enrollment: 36 patients

Sex: Male

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male
• Aged between 18-35 years inclusive
• Healthy, moderately active
• BMI < 30 kg/m2 and > 18.5 kg/m2
• Having given informed consent

Exclusion criteria

• Presence of any identified metabolic or intestinal disorders
• Use of tobacco products
• Allergies to milk proteins (whey or casein)
• Lactose intolerance
• Phenylketonuria (PKU)
• A history of neuromuscular problems
• Previous participation in amino acid tracer studies
• Adherence to a strict vegetarian or vegan diet
• Current use of ketone supplements or adherence to a ketogenic diet
• Use of medications known to affect protein metabolism
• Diagnosis of Diabetes
• Engagement in sports or physical exercise 5 or more days per week

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

36 participants in 3 patient groups

Ketone

Experimental group

Description:

Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and carbohydrate control.

Treatment:

Dietary Supplement: Ketone

Ketone + Protein

Experimental group

Description:

Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and 10g of whey protein.

Treatment:

Dietary Supplement: Ketone + Protein

Protein

Experimental group

Description:

Carbohydrate control and 10g of whey protein.

Treatment:

Dietary Supplement: Protein